Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

35
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
35
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

2.1K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.1K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

602
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
602
Inflammation01:38

Inflammation

65.2K
Overview
65.2K
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

2.0K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
2.0K
Inflammatory Response01:28

Inflammatory Response

19.6K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
19.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DHCR24 inhibition upregulates desmosterol without promoting regression of atherosclerotic plaques in APOE*3-Leiden.CETP mice.

Steroids·2026
Same author

Transcriptional and chromatin dynamics in macrophage differentiation and activation.

Science immunology·2026
Same author

Female-Biased VSMC GRNs Predict MYH9 as Regulator of Fibrous Plaque Phenotype.

Circulation research·2026
Same author

Carotid plaque macrophage burden and inflammatory lipid-associated macrophage markers predict secondary major adverse cardiovascular events after endarterectomy.

European heart journal·2026
Same author

Systemically inducing trained immunity overcomes solid tumors' immunosuppressive microenvironment.

Science advances·2026
Same author

Human monocyte inflammation in patients with Lp(a) or atherosclerotic cardiovascular disease is not accompanied by changes in chromatin accessibility in circulating classical monocytes.

Journal of clinical lipidology·2025

Related Experiment Video

Updated: Apr 12, 2026

Mouse Models for Graft Arteriosclerosis
07:37

Mouse Models for Graft Arteriosclerosis

Published on: May 14, 2013

14.3K

Interferons as Essential Modulators of Atherosclerosis.

Marieke C S Boshuizen1, Menno P J de Winther2

  • 1From the Experimental Vascular Biology, Department of Medical Biochemistry, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.

Arteriosclerosis, Thrombosis, and Vascular Biology
|May 9, 2015
PubMed
Summary

Interferons (IFNs) are crucial immune regulators implicated in atherosclerosis. This review explores how type I and type II IFNs influence atherosclerosis development and their potential as therapeutic targets.

Keywords:
apoptosisatherosclerosiscytokinesfoam cellsinterferons

More Related Videos

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

13.9K
A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

13.9K

Related Experiment Videos

Last Updated: Apr 12, 2026

Mouse Models for Graft Arteriosclerosis
07:37

Mouse Models for Graft Arteriosclerosis

Published on: May 14, 2013

14.3K
High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

13.9K
A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

13.9K

Area of Science:

  • Immunology
  • Cardiovascular Research
  • Molecular Biology

Background:

  • Interferons (IFNs) are vital cytokines regulating innate and adaptive immunity.
  • Type I and type II IFNs are well-defined subtypes with significant roles in inflammatory diseases.
  • IFNs are recognized as important mediators in the development of atherosclerosis.

Purpose of the Study:

  • To review the current understanding of type I and type II interferons in atherosclerosis.
  • To focus on the specific roles of IFNs in key pathogenic processes of atherosclerosis.
  • To evaluate the potential of IFNs as therapeutic targets for atherosclerosis.

Main Methods:

  • This is a review article, synthesizing existing in vitro and in vivo study findings.
  • Literature search and analysis of studies investigating IFN roles in atherosclerosis.
  • Focus on mechanisms including endothelial activation, cell recruitment, foam cell formation, and apoptosis.

Main Results:

  • IFNs, particularly type I and type II, are generally considered proatherosclerotic.
  • Distinct roles for IFNs exist across different stages of atherosclerosis development.
  • IFNs impact crucial cellular processes involved in atherosclerotic plaque formation.

Conclusions:

  • Type I and type II interferons play a complex, often proatherosclerotic role in disease development.
  • Understanding these roles is critical for developing targeted therapies.
  • Interferons represent a potential avenue for novel therapeutic interventions in atherosclerosis.